|
C17ORF90 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.371900E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.589400E-01 |
| Normal-vs-Stage2 |
2.339400E-01 |
| Normal-vs-Stage3 |
9.412200E-02 |
| Normal-vs-Stage4 |
3.763300E-03 |
| Stage1-vs-Stage2 |
6.022000E-01 |
| Stage1-vs-Stage3 |
4.253800E-01 |
| Stage1-vs-Stage4 |
3.597800E-02 |
| Stage2-vs-Stage3 |
9.907400E-01 |
| Stage2-vs-Stage4 |
2.257600E-01 |
| Stage3-vs-Stage4 |
1.099790E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.172000E-01 |
| Normal-vs-AfricanAmerican |
6.29669999999694E-05 |
| Normal-vs-Asian |
1.825590E-01 |
| Caucasian-vs-AfricanAmerican |
1.013350E-04 |
| Caucasian-vs-Asian |
2.078000E-01 |
| AfricanAmerican-vs-Asian |
6.533200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.263200E-01 |
| Normal-vs-Female |
1.435780E-02 |
| Male-vs-Female |
8.140200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.510200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.916800E-01 |
| Normal-vs-Age(61-80Yrs) |
6.253700E-02 |
| Normal-vs-Age(81-100Yrs) |
1.897020E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.049800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.767800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.386000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.543800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.541800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.209600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.918000E-01 |
| Normal-vs-Grade 2 |
9.667000E-01 |
| Normal-vs-Grade 3 |
4.036200E-02 |
| Normal-vs-Grade 4 |
4.241100E-04 |
| Grade 1-vs-Grade 2 |
4.117400E-01 |
| Grade 1-vs-Grade 3 |
9.842800E-01 |
| Grade 1-vs-Grade 4 |
3.395400E-01 |
| Grade 2-vs-Grade 3 |
3.418400E-02 |
| Grade 2-vs-Grade 4 |
3.409300E-04 |
| Grade 3-vs-Grade 4 |
5.310200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.697700E-02 |
| Normal-vs-ccB subtype |
3.639000E-01 |
| ccA subtype-vs-ccB subtype |
5.661500E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.937420E-01 |
| Normal-vs-N1 |
3.972400E-02 |
| N0-vs-N1 |
4.925700E-02 |
|
|
